Evidence map›Paper›PMID 31198493›Full record

ArticleOxidative medicine and cellular longevity2019

Antiepileptic Effects of Protein-Rich Extract from

Meibian Hu, Yujie Liu, Liying He, Xing Yuan, Wei Peng, Chunjie Wu

Open access · hybridAbstract read
In one paragraph

Article in Oxidative medicine and cellular longevity, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it, 41 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Synthesis of Nano-Selenium fromMolecules (Basel, Switzerland) · 2025
    Article
  6. Review
  7. Article
  8. Article
  9. Characterization of Polysaccharides from the Pericarp ofMolecules (Basel, Switzerland) · 2023
    Article
  10. Neuroprotective Effect ofBioengineering (Basel, Switzerland) · 2022
    Article
  11. Article
  12. Analysis of Medication Rule of Primary Epilepsy Based onEvidence-based complementary and alternative medicine : eCAM · 2022
    Article
  13. Evidence-based complementary and alternative medicine : eCAM · 2022
    Article
  14. Article
  15. Article
  16. Molecules (Basel, Switzerland) · 2021
    Article
  17. Article
  18. Chinese Herbal Medicine for Treating Epilepsy.Frontiers in neuroscience · 2021
    Review
  19. Article
  20. The Effect of Protein-Rich Extract fromMolecules (Basel, Switzerland) · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Meibian HuSchool of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.ORCID 0000-0002-3441-8910
Yujie LiuSchool of Pharmacy, Chengdu Medical College, Chengdu 610500, China.ORCID 0000-0002-9101-199X
Liying HeSchool of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.ORCID 0000-0001-8890-7624
Xing YuanSchool of Medicine and Life Sciences, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.ORCID 0000-0003-3411-7656
Wei PengSchool of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.ORCID 0000-0003-0511-9564
Chunjie WuSchool of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.ORCID 0000-0001-7496-8469
Chengdu University of Traditional Chinese Medicine · CNChengdu Medical College · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsAnticonvulsantsAntioxidantsApoptosisBombyxCell SurvivalConvulsantsElectroshockGene Expression RegulationHydrogen PeroxideInsect ProteinsMaleMalondialdehydeMiceNeuroprotective AgentsOxidantsAnticonvulsantsAntioxidantsConvulsantsHydrogen PeroxideInsect ProteinsMalondialdehydeNeuroprotective AgentsOxidantsPentylenetetrazolePhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-akt

Identifiers

PMID31198493
PMCPMC6526569
OpenAlexW2942732154

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.